Litigation Details for PURDUE PHARMACEUTICALS PRODUCTS L.P. v. LANNETT HOLDINGS, INC. (D.N.J. 2015)
✉ Email this page to a colleague
PURDUE PHARMACEUTICALS PRODUCTS L.P. v. LANNETT HOLDINGS, INC. (D.N.J. 2015)
Docket | ⤷ Sign Up | Date Filed | 2015-08-06 |
Court | District Court, D. New Jersey | Date Terminated | 2016-07-22 |
Cause | 35:271 Patent Infringement | Assigned To | Susan Davis Wigenton |
Jury Demand | None | Referred To | Leda Dunn Wettre |
Parties | LANNETT COMPANY, INC. | ||
Patents | 6,589,960 | ||
Attorneys | DAVID L. HECHT | ||
Link to Docket | External link to docket |
Small Molecule Drugs cited in PURDUE PHARMACEUTICALS PRODUCTS L.P. v. LANNETT HOLDINGS, INC.
Details for PURDUE PHARMACEUTICALS PRODUCTS L.P. v. LANNETT HOLDINGS, INC. (D.N.J. 2015)
Date Filed | Document No. | Description | Snippet | Link To Document |
---|---|---|---|---|
2015-08-06 | 1 | BACKGROUND 21. United States Patent No. 6,589,960 (“the ‘960 Patent”), entitled “Hydromorphone And…interest in the ‘960 Patent, including the right to sue for infringement of the ‘960 Patent. 23. …the expiration of the ‘960 Patent constitutes infringement of the ‘960 Patent. 31. Upon information… 8. This cause of action arises under the Patent laws of the United States, Title 35, United States…has jurisdiction over the subject matter of this patent infringement action pursuant to 28 U.S.C. §§ 1331 | External link to document | |
2015-11-30 | 14 | prior to the expiration of U.S. Patent No. 6,589,960 (“the ‘960 patent”). Lannett admits that paragraph… the U.S. Patent and Trademark Office of July 8, 2003. Lannett denies that the ‘960 patent was duly and…891. The Patent and Exclusivity Information provided by the Orange Book lists the ‘960 patent. …during the terms of the ’960 patent would infringe the claims of that patent. 14. Plaintiffs… of the ’960 patent. 22. One or more of the claims of the ’960 patent are invalid for | External link to document | |
>Date Filed | >Document No. | >Description | >Snippet | >Link To Document |